CD82 and melanoma: MiR-338-3p also significantly inhibited TC cell proliferation, motility, and in vivo growth via AKT3 targeting .[133] It was reported that there was miR-338-5p upregulation in melanoma tissues that was conversely associated with CD82 expression levels.